Industry Insights
-
Five APAC Markets, Five Regulatory Models: What Developers Should Know
11/19/2026
The ISCT has mapped regulatory approval pathways for five nations in one of the world's fastest growing markets for cell and gene therapy.
-
Applying The Multiproduct Manufacturing Model To Autologous Cell Therapy
11/19/2026
When each batch has a patient count of one, established segregation and traceability principals for biologics offer a useful roadmap.
-
You Can't CAPA What You Can't Locate
11/16/2026
Don’t reinvent the wheel — adapt it. Locate before you correct, because where a failure appears isn’t necessarily where it gets fixed.
-
Safety, Durability, And Trial Design: Testing One-Time Dose To Slow Huntington's
11/16/2026
Part 2 in this series explores the lingering unknowns in Latus Bio's move toward IND with its intrastriatially-delivered, engineered AAV gene therapy.
-
Computational Model Predicts Huntington's Drug Performance
11/16/2026
Latus Bio built a computational model that predicts suppression of CAG trinucleotide repeats based on historical data, then released it for anyone on GitHub.
-
Comparing Advanced Modality Needs, Part 1: Manufacturing
11/13/2026
ADCs, AOCs, ATMPs, cell and gene therapies, and oligonucleotide therapeutics represent distinct but interconnected approaches to precision medicine. Let's take a closer look at their manufacturing needs.
-
What Will It Take To Turn CGT Innovation Into Market Success?
11/11/2026
This session recap from Advanced Therapies USA Congress 2026 explains why the CGT industry cannot evaluate success through clinical data alone.
-
Why CMC Must Shape Critical Decisions Early In Development
11/11/2026
Case studies reveal the gap between research progress and clinical readiness. In these stories, earlier CMC involvement might have saved resources and staved off delays.
-
Developing Your Vapor Phase Hydrogen Peroxide Cycle
11/10/2026
Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.
-
Closing The Gap Between Modeling And GMP Predictive Control
11/10/2026
Predictive control offers opportunities to improve process consistency, reduce variability, and respond to changing manufacturing conditions before they cause deviations.